Quantcast

Latest myasthenia gravis Stories

2011-07-21 07:11:00

SAN MATEO, Calif., July 21, 2011 /PRNewswire/ -- Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN® (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients. Photos/Multimedia Gallery Available: http://www.news2know.net/mnr/merz-aesthetics/xeomin.php "The FDA approval of XEOMIN is a significant...

2011-06-02 22:14:41

Improving the strength of patients with Myasthenia Gravis, a disease characterized by varying degrees of muscular weakness, is the goal of a new study being conducted at Baylor College of Medicine. Volunteers are needed to test the effectiveness of an investigational drug that may partially improve muscle strength in patients with this disease, said Dr. Yadollah Harati, professor of neurology and lead investigator on the clinical trial. Myasthenia Gravis is a chronic autoimmune neuromuscular...

2011-06-02 14:00:00

NEW YORK, June 2, 2011 /PRNewswire/ -- Who: Fernando Ferrer, former NYC mayoral candidate and MG patient, will be joining hundreds of walkers at the 2011 TriState MG Walk on Sunday, June 12 at Riverside Park in Manhattan. To date, more than 1,200 walkers have registered across the nation and raised nearly $300,000 for this awareness and fundraising campaign that has taken place in Florida, Wisconsin and in the upcoming TriState area. Many more MG Walks are planned for later in 2011 and...

2011-04-18 10:56:00

NEW YORK, April 18, 2011 /PRNewswire/ -- What: The MG Walk is a new signature fundraising campaign designed to provide hope for the thousands of families forced to face the challenges caused by myasthenia gravis. On Saturday, April 30th, The MG Walk comes to Greenfield Park in West Allis, Milwaukee County in order to raise funds and awareness for the MGFA! This effort will raise funds to help us continue our mission to provide programs to assist those living with MG and fund research, in...

2011-03-30 07:11:00

GREENSBORO, N.C., March 30, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC announced today that the Centers for Medicare and Medicaid Services (CMS) has granted a unique Healthcare Common Procedure Coding System (HCPCS) billing code, Q2040, for Xeomin® (incobotulinumtoxinA). Merz expects that this unique billing code, which will become effective on April 1, 2011, will help simplify the billing and reimbursement process for prescribers of XEOMIN. The U.S. Food and Drug...

2011-03-08 07:11:00

GREENSBORO, N.C., March 8, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced the launch of two programs to provide financial assistance to patients for their treatment with Xeomin® (incobotulinumtoxinA). XEOMIN is a botulinum toxin type A free from accessory proteins that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with cervical dystonia, to decrease the severity of abnormal head position and neck pain in both botulinum...

2010-10-05 07:11:00

GREENSBORO, N.C., Oct. 5 /PRNewswire/ -- Merz Pharmaceuticals today announced that Xeomin® (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010. XEOMIN is a botulinum toxin type A that is free from accessory proteins. It is FDA-approved for the treatment of adults with...

2009-11-13 16:07:00

HOUSTON, Nov. 13 /PRNewswire/ -- Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be. No one could figure out what was wrong. Not the 13 doctors her distraught parents saw in Syria, not the specialists in Britain who had reviewed her chart, not the additional physicians she had seen in Iraq, the war-torn country the family had fled in a desperate effort to find the...

2008-07-31 09:01:26

Amarin Corporation plc (NASDAQ:AMRN) announced that at its Annual General Meeting (AGM) held in Dublin today, shareholders approved all of the thirteen resolutions set out in the AGM notice. About Amarin Amarin is a biopharmaceutical company focused on improving the lives of patients suffering from cardiovascular and central nervous system (CNS) diseases. Amarin's cardiovascular programs, including AMR101 for hypertriglyceridemia, capitalize on the known therapeutic benefits of...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related